Skip to content
Menu
Home
About Us
Life Wins
Chairman’s Profile
Board Of Directors
Team Wockhardt
Corporate Milestones
Research & Development
R&D at Wockhardt
New Drug Discovery
Pipeline / Projects
News & Events
Publications
WCK 5222
WCK 4873
WCK 4282
WCK 6777
Biologicals
News & Events
Pipeline / Projects
Publications
R&D Contact
Our Business Verticals
Our Manufacturing Units
Global Footprint
India
UK & Europe
US
Emerging Markets
Products
India Branded Business
Trademark Products
Quality
Digital Footprint
Awards & Recognitions
Investors
From Chairman’s Office
AGM Speech
Letter to Shareowners
Financials
Financials at a Glance
Annual Report
Quarterly Results
Financial Press Releases
Related Party Transactions
Subsidiary Financials
Annual Return
Corporate Governance
Policies & Codes
Committee’s of the Board
Familiarisation programs
Shareholding Pattern
Secretarial Compliance Report
Authorised KMP
Corporate Actions
Announcements / Disclosures
Shareholders Meeting/ Postal ballot
AGM Notice
Proceedings
IEPF
Unclaimed Dividend
Nodal Officer
Analyst/ Investors
Presentation
Audio / Video Recording
Transcript
Shareowner Services
FAQ
Green Initiative
Investor Contact
Stock Quotes
Credit Rating
careers
Introduction
Life@Wockhardt
L&D Initiatives
Voice of Wockhardians
The Wockhardian
Career@Wockhardt
Media
Press Release
Media Coverage
Video Coverage
Media Kit
Sustainability
Contact us
Home
/
2021-2022
/
Page 5
PDF Year:
2021-2022
Home
Vaccine Manufacturing Agreement 12 – 08 – 2021
Chairman’s Letter to Shareowners Q1 FY21 – 22
HUGELY SUCCESSFUL VACCINATION ROLL OUT MADE POSSIBLE BY UK – INDIAN BUSINESS PARTNERSHIP
Vaccination rollout in UK 27 – 07 – 2021
Q1 (APR – JUN 2021) FINANCIAL RESULTS FY22
Appointment of CS & resignation of CFO 22 – 07 – 2021
WOCKHARDT UK PROUDLY HOSTS VISIT OF HRH THE PRINCE OF WALES
Visit of HRH 05 – 07 – 2021
Shareholding Pattern for the Quarter Ended 30th June, 2021
Q4 (JAN – MAR 2021) FINANCIAL RESULTS FY21
Posts navigation
Previous page
Page
1
…
Page
4
Page
5
Page
6
Next page
